Home › Research › Vascular contributions
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Sarah E. Vermeer, Niels D. Prins, Tom den Heijer, Albert Hofman, Peter J. Koudstaal, Monique M.B. Breteler. New England Journal of Medicine, 2003-03-26
Topic: Risk, prevention and care in population studies
Plain-language summary
During 3697 person-years of follow-up (mean per person, 3.6 years), dementia developed in 30 of the 1015 participants. The presence of silent brain infarcts at base line more than doubled the risk of dementia (hazard ratio, 2.26; 95 percent confidence interval, 1.09 to 4.70). The presence of silent brain infarcts on the base-line MRI was associated with worse performance on neuropsychological tests and a steeper decline in global cognitive function. Silent thalamic infarcts were associated with a decline in memory performance, and nonthalamic infarcts with a decline in psychomotor speed. When participants with silent brain infarcts at base line were subdivided into those with and those without additional infarcts at follow-up, the decline in cognitive function was restricted to those with additional silent infarcts. Elderly people with silent brain infarcts have an increased risk of dementia and a steeper decline in cognitive function than those without such lesions.
What this study adds
Evidence grade: Low
The record lists 1,015 participants. This study found that silent brain infarcts in elderly people were associated with more than double the risk of dementia and a steeper decline in cognitive function. It does not test a treatment or cure, but identifies a possible risk factor for dementia.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. (2003). Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline. New England Journal of Medicine. https://doi.org/10.1056/nejmoa022066
Vancouver
Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline. New England Journal of Medicine. 2003. doi:10.1056/nejmoa022066. PMID: 12660385.
BibTeX
@article{vermeer2003-12660385,
author = {Vermeer, Sarah E. and Prins, Niels D. and den Heijer, Tom and Hofman, Albert and Koudstaal, Peter J. and Breteler, Monique M.B.},
title = {{Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline}},
journal = {New England Journal of Medicine},
year = {2003},
doi = {10.1056/nejmoa022066},
pmid = {12660385},
url = {https://doi.org/10.1056/nejmoa022066}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- During 3697 person-years of follow-up (mean per person, 3.6 years), dementia developed in 30 of the 1015 participants.
- The presence of silent brain infarcts at base line more than doubled the risk of dementia (hazard ratio, 2.26; 95 percent confidence interval, 1.09 to 4.70).
- The presence of silent brain infarcts on the base-line MRI was associated with worse performance on neuropsychological tests and a steeper decline in global cognitive function.
- Silent thalamic infarcts were associated with a decline in memory performance, and nonthalamic infarcts with a decline in psychomotor speed.
- When participants with silent brain infarcts at base line were subdivided into those with and those without additional infarcts at follow-up, the decline in cognitive function was restricted to those with additional silent infarcts.
Why it matters
This study found that silent brain infarcts in elderly people were associated with more than double the risk of dementia and a steeper decline in cognitive function. It does not test a treatment or cure, but identifies a possible risk factor for dementia.
Study details
- Participants1,015
- Evidence strengthLow
How this study scored 67/100
Published in a top-tier journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 10 / 10 | Tier 1 — top-tier general journal (New England Journal of Medicine) |
| Journal's citation record | 4 / 4 | New England Journal of Medicine: journal h-index 1,505 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2003 — older than 20 years, still counted |
| Sample size | 3 / 4 | 1,015 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 7 / 7 | Cited 2,311 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 92.4 citations a year over 25 year(s) since 2003 |
| Impact for its field and year | 6 / 6 | Cited 57.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 5 / 6 | Cited by 110 other studies in this library |
| Still being cited | 3 / 4 | Cited 195 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Monique M.B. Breteler: h-index 162 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Erasmus MC: institution h-index 1,321 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 12660385) |
| Free to read | 2 / 2 | Free to read |
| Total | 67 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1056/nejmoa022066
- PubMed: 12660385
- Original source →
- Free full text: New England Journal of Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 16.
Later studies that cite this one
110 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Vascular contributions from nearby years
Also tagged “small”
900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.